T. Rowe Price Associates’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-93,646
Closed -$97K 2941
2023
Q2
$97K Sell
93,646
-63,766
-41% -$59.4K ﹤0.01% 2704
2023
Q1
$215K Buy
157,412
+5,364
+4% +$7.66K ﹤0.01% 2492
2022
Q4
$233K Buy
152,048
+3,073
+2% +$6.86K ﹤0.01% 2475
2022
Q3
$436K Buy
148,975
+4,678
+3% +$12.8K ﹤0.01% 2193
2022
Q2
$267K Sell
144,297
-28,394
-16% -$83.6K ﹤0.01% 2491
2022
Q1
$753K Buy
172,691
+30,115
+21% +$135K ﹤0.01% 2149
2021
Q4
$771K Buy
142,576
+2,738
+2% +$25.6K ﹤0.01% 2155
2021
Q3
$1.92M Buy
139,838
+41,500
+42% +$594K ﹤0.01% 1748
2021
Q2
$1.61M Sell
98,338
-980,785
-91% -$14.6M ﹤0.01% 1836
2021
Q1
$20.6M Buy
1,079,123
+1,019,968
+1,724% +$14.8M ﹤0.01% 1270
2020
Q4
$365K Buy
+59,155
New +$189K ﹤0.01% 2360

Other funds holding AMRS

T. Rowe Price Associates's AMRS Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 93,646 shares — an estimated $97K sold.

T. Rowe Price Associates first reported a position in AMRS in Q4 2020 and held it in 11 quarters. The position peaked at $20.6M in Q1 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 93,646 Amyris Inc. shares in Q3 2023, an estimated $97K.
  • T. Rowe Price Associates first reported a position in Amyris Inc. in Q4 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Amyris Inc. position peaked at $20.6M in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.